Financial reports
10-Q
2023 Q2
Quarterly report
11 Aug 23
10-Q
2023 Q1
Quarterly report
15 May 23
ARS
2022 FY
Annual report to shareholders
28 Apr 23
10-K
2022 FY
Annual report
14 Mar 23
10-Q
2022 Q3
Quarterly report
9 Nov 22
10-Q
2022 Q2
Quarterly report
10 Aug 22
10-Q
2022 Q1
Quarterly report
12 May 22
10-K
2021 FY
Annual report
18 Mar 22
10-Q
2021 Q3
Quarterly report
10 Nov 21
10-Q
2021 Q2
Quarterly report
10 Aug 21
Current reports
8-K
Completion of Acquisition or Disposition of Assets
25 Sep 23
8-K
Other Events
25 Aug 23
8-K
Tender and Support Agreement
9 Aug 23
8-K
Submission of Matters to a Vote of Security Holders
13 Jun 23
8-K
Amendments to Articles of Incorporation or Bylaws
6 Apr 23
8-K
Departure of Directors or Certain Officers
21 Mar 23
8-K
Regulation FD Disclosure
10 Mar 23
8-K
Regulation FD Disclosure
9 Jan 23
8-K
Other Events
17 Oct 22
8-K
Departure of Directors or Certain Officers
12 Oct 22
Registration and prospectus
15-12G
Securities registration termination
10 Oct 23
S-8 POS
Registration of securities for employees (post-effective amendment)
25 Sep 23
S-8 POS
Registration of securities for employees (post-effective amendment)
25 Sep 23
S-8 POS
Registration of securities for employees (post-effective amendment)
25 Sep 23
POS AM
Prospectus update (post-effective amendment)
25 Sep 23
SC 14D9/A
Tender offer solicitation (amended)
25 Sep 23
25-NSE
Exchange delisting
25 Sep 23
SC TO-T/A
Third party tender offer statement (amended)
25 Sep 23
SC TO-T/A
Third party tender offer statement (amended)
12 Sep 23
SC 14D9/A
Tender offer solicitation (amended)
12 Sep 23
Other
EFFECT
Notice of effectiveness
6 Oct 23
EFFECT
Notice of effectiveness
18 May 22
CORRESP
Correspondence with SEC
13 May 22
UPLOAD
Letter from SEC
24 Mar 22
EFFECT
Notice of effectiveness
12 Feb 21
SEC STAFF
SEC staff action: Order
11 Feb 21
CERT
Certification of approval for exchange listing
9 Feb 21
CORRESP
Correspondence with SEC
9 Feb 21
CORRESP
Correspondence with SEC
9 Feb 21
CORRESP
Correspondence with SEC
28 Jan 21
Ownership
SC 13G/A
CITADEL ADVISORS LLC
14 Feb 24
SC 13D/A
REGENERON PHARMACEUTICALS, INC.
27 Sep 23
4
Anna Trask
25 Sep 23
4
William H. Carson
25 Sep 23
4
John Jui-Jen Lee
25 Sep 23
4
ALISON CECILY FINGER
25 Sep 23
4
KEVIN F MCLAUGHLIN
25 Sep 23
4
Laurence Reid
25 Sep 23
4
Matthew C Kapusta
25 Sep 23
4
Sara Nochur
25 Sep 23